covid-19 drug | sciencenewsnet.in

Breaking News

New research sheds light on a surprising connection between COVID-19 and cancer regression

Research finds no significant negative impact of repealing a Depression-era law allowing companies to pay workers with disabilities below minimum wage

Low-frequency magnetic field (LFMF) for enhanced carotenoids production by Rhodotorula glutinis

AAOS Sweeps Three Top Workplace Honors Locally and Nationally in 2024

Texas Tech Health El Paso Schools Recognized in U.S. News & World Report’s Best Colleges Rankings

University of Chicago Medical Center Receives 26th Consecutive “A” in Hospital Safety from Leapfrog Group

Hackensack Meridian Jersey Shore University and Hackensack University Medical Centers Achieve Excellence in Life Support Care

International Cancer Organizations Present Collaborative Work During Oncology Event in China

ETRI-F&U Credit Information Co., Ltd., Opens a New Path for AI-Based Professional Consultation

One or many? Exploring the population groups of the largest animal on Earth

15 Nov, 2024

Montefiore-Einstein Researchers Test Whether Molnupiravir Can Prevent COVID-19

November 4, 2021 sarah JonasFeature

As part of a recently launched international phase 3 clinical trial, Montefiore Health System and Albert Einstein College of Medicine are investigating whether the Merck antiviral pill, molnupiravir, now approved in Britain for treating COVID-19, can prevent COVID-19 in unvaccinated individuals living with people who have contracted the disease. Montefiore-Einstein is the first and only New York State site for the trial and was selected due to its diverse patient population and expertise in clinical trials of COVID-19 and other infectious diseases.